3NX Stock Overview
An investment holding company, provides assisted reproductive services (ARS) in China and the United States.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
Jinxin Fertility Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.32 |
| 52 Week High | HK$0.57 |
| 52 Week Low | HK$0.24 |
| Beta | 1.43 |
| 11 Month Change | -14.97% |
| 3 Month Change | 11.19% |
| 1 Year Change | -33.75% |
| 33 Year Change | -84.41% |
| 5 Year Change | -68.95% |
| Change since IPO | -66.28% |
Recent News & Updates
Recent updates
Shareholder Returns
| 3NX | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -6.5% | -1.5% | 0.09% |
| 1Y | -33.8% | 0.8% | 3.1% |
Return vs Industry: 3NX underperformed the German Healthcare industry which returned 0.7% over the past year.
Return vs Market: 3NX underperformed the German Market which returned 3% over the past year.
Price Volatility
| 3NX volatility | |
|---|---|
| 3NX Average Weekly Movement | 8.2% |
| Healthcare Industry Average Movement | 5.3% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.7% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 3NX's share price has been volatile over the past 3 months.
Volatility Over Time: 3NX's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1951 | 3,273 | Yang Dong | www.jxr-fertility.com |
Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States. The company primarily offers two treatment solutions, including artificial insemination that is performed with either husband’s sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection. It also provides related services, such as nutrition guidance, Chinese medicine treatment, and psychological counseling to support the ARS.
Jinxin Fertility Group Limited Fundamentals Summary
| 3NX fundamental statistics | |
|---|---|
| Market cap | €907.44m |
| Earnings (TTM) | €44.32m |
| Revenue (TTM) | €358.53m |
20.5x
P/E Ratio2.5x
P/S RatioIs 3NX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 3NX income statement (TTM) | |
|---|---|
| Revenue | CN¥2.79b |
| Cost of Revenue | CN¥1.61b |
| Gross Profit | CN¥1.18b |
| Other Expenses | CN¥830.72m |
| Earnings | CN¥344.72m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.13 |
| Gross Margin | 42.15% |
| Net Profit Margin | 12.36% |
| Debt/Equity Ratio | 23.2% |
How did 3NX perform over the long term?
See historical performance and comparisonDividends
2.1%
Current Dividend Yield42%
Payout RatioDoes 3NX pay a reliable dividends?
See 3NX dividend history and benchmarks| Jinxin Fertility Group dividend dates | |
|---|---|
| Ex Dividend Date | Jun 27 2024 |
| Dividend Pay Date | Jul 25 2024 |
| Days until Ex dividend | 2 days |
| Days until Dividend pay date | 26 days |
Does 3NX pay a reliable dividends?
See 3NX dividend history and benchmarks